Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: A review

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 12, 2008, Pages 3298-3305

  Bag, Arundhati ^a   Bag, Niladri ^b  

^a UFHT Medical College Campus   (India)

^b Biotech Bhavan   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME P450 1B1; HYDROGEN PEROXIDE; IRON SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE; SUPEROXIDE;

AMINO ACID SUBSTITUTION; APOPTOSIS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CARCINOGENESIS; CELL ADHESION; CELL PROLIFERATION; COLORECTAL ADENOMA; CYTOSOL; DIGESTIVE SYSTEM CANCER; GENE INTERACTION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE ENVIRONMENT INTERACTION; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; MITOCHONDRION; MOLECULAR DYNAMICS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN TARGETING; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SEQUENCE ANALYSIS; SYSTEMATIC REVIEW;

ALANINE; ALLELES; ANTIOXIDANTS; BREAST NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; POLYMORPHISM, GENETIC; SUPEROXIDE DISMUTASE; VALINE;

EID: 57449112772     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0235     Document Type: Review

References (57)

1. Storz P. Reactive oxygen species in tumor progression. Front Biosci 2005;10:1881-96.
2. Tamimi RM, Hankinson SE, Spiegelman D, Colditz GA, Hunter DJ. Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2004;13:989-96.
3. Kang D, Lee KM, Park SK, et al. Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers Prev 2007;16:1581-6.
4. Rosenblum JS, Gilula NB, Lerner RA. On signal sequence polymorphisms and diseases of distribution. Proc Natl Acad Sci U S A 1996;93:4471-3.
5. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochem Biophys Res Commun 1996;226:561-5.
6. 16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 2003;13:145-57.
7. Ambrosone CB, Ahn J, Singh KK, et al. Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer. Cancer Res 2005;65:1105-11.
8. Silva SN, Cabral MN, De Castro GB, et al. Breast cancer risk and polymorphisms in genes involved in metabolism of estrogens (CYP17, HSD17β1, COMT and MnSOD): possible protective role of MnSOD gene polymorphism Val/Ala and Ala/Ala in women that never breast fed. Oncol Rep 2006;16:781-8.
9. Cox DG, Tamimi RM, Hunter DJ. Gene x gene interaction between MnSOD and GPX-1 and breast cancer risk: a nested case-control study. BMC Cancer 2006;6:217-9.
10. Bergman M, Ahnstrom M, Plameback Wegman P, Wingren S. Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women. J Cancer Res Clin Oncol 2005;131:439-44.
11. Mitrunen K, Sillanpaa P, Kataja V, et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis 2001;22:827-9.
12. 9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and Whites. Breast Cancer Res 2004;6:R264-74.
13. Ambrosone CB, Freudenheim JL, Thompson PA, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 1999;59:602-6.
14. Cai Q, Shu X-O, Wen W, et al. Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Breast Cancer Res 2004;6:R647-55.
15. Choi JY, Neuhouser ML, Barnett M, et al. Iron intake, oxidative stress-related genes (MnSOD and MPO), and prostate cancer risk in CARET cohort. Carcinogenesis 2008;29:964-70.
16. Kocabas NA, Sardas S, Cholerton S, Daly AK, Elhan AH, Karakaya AE. Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility. Cell Biochem Funct 2005;23:73-6.
17. Egan KM, Thompson PA, Titus-Ernstoff L, Moore JH, Ambrosone CB. MnSOD polymorphism and breast cancer in a population-based case-control study. Cancer Lett 2003;199:27-33.
18. 9Ala genotype, pro- and anti-oxidant environmental modifiers, and breast cancer among women on Long Island, New York. Cancer Causes Control 2005;16:1225-34.
19. Woodson K, Tangrea JA, Lehman TA, et al. Manganese superoxide dismutase (MnSOD) polymorphism, α-tocopherol supplementation and prostate cancer risk in the α-Tocopherol, β-Carotene Cancer Prevention study (Finland). Cancer Causes Control 2003;14:513-8.
20. 9Val polymorphism on prostate cancer: a case control study. Anticancer Res 2007;27:1227-30.
21. Stoehlmacher J, Ingles SA, Park DJ, Zhang W, Lenz HJ. The -9Ala/-9Val polymorphism in the mitochondrial targeting sequence of the manganese superoxide dismutase gene (MnSOD) is associated with age among Hispanics with colorectal carcinoma. Oncol Rep 2002;9:235-8.
22. Levine AJ, Elkhouly E, Diep AT, Lee ER, Frankl H, Haile RW. The MnSOD A16V mitochondrial targeting sequence polymorphism is not associated with increased risk of distal colorectal adenomas: data from a sigmoidoscopy-based case control study. Cancer Epidemiol Biomarkers Prev 2002;11:1140-1.
23. Martin RC, Lan Q, Hughes K, et al. No apparent association between genetic polymorphisms (-102 C>T) and (-9T>C) in the human manganese superoxide gene and gastric cancer (1). J Surg Res 2005;124:92-7.
24. Hung RJ, Boffetta P, Brennan P, et al. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis 2004;25:973-8.
25. Fong CS, Wu RM, Shieh JC, et al. Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease. Clin Chim Acta 2007;378:136-41.
26. Galecki P, Pietras T, Szemraj J, et al. Functional polymorphism of manganese superoxide dismutase (MnSOD) gene correlates with schizophrenia in Polish population. Pol Merkur Lekarski 2006;20:329-32.
27. Degoul F, Sutton A, Mansouri A, et al. Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. Gastroenterology 2001;120:1468-74.
28. Ho JC, Mak JC, Ho SP, et al. Manganese superoxide dismutase and catalase genetic polymorphisms, activity levels, and lung cancer risk in Chinese in Hong Kong. J Thoracic Oncol 2006;1:648-53.
29. Lin P, Hsueh YM, Ko JL, Liang YF, Tsai KJ, Chen CY. Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan. Lung Cancer 2003;40:123-9.
30. Mak JCW, Leung HCM, Ho SP, et al. Polymorphisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients. Clin Exp Allergy 2006;36:440-7.
31. Kakko S, Paivansalo M, Koistinen P, Kesaniemi A, Kinnula VL, Savolainen MJ. The signal sequence polymorphism of the MnSOD gene is associated with the degree of carotid atherosclerosis. Atherosclerosis 2003;168:147-52.
32. Gottlieb MG, Schwanke CH, Santos AF, Jobim PF, Mussel DP, da Cruz IB. Association among oxidized LDL levels, MnSOD, apolipoprotein E polymorphisms, and cardiovascular risk factors in a south Brazilian region population. Genet Mol Res 2005;4:691-703.
33. 9Val mitochondrial targeting sequence polymorphism in systemic lupus erythematosus in Poland. Clin Rheumatol 2007. Online publication.
34. Arisan ED, Arisan S, Kiremit MC, et al. Manganese superoxide dismutase polymorphism in chronic pelvic pain syndrome patients. Prostate Cancer Prostatic Dis 2006;9:426-31.
35. Saadat M, Ansari-Lari M. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res Treat. Epub ahead of print.
36. Hu Z, Ma H, Chen F, Wei Q, Shen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 2005;14:1810-8.
37. Wolf FM. Meta-analysis: quantitative methods for research synthesis. Sage University; 1986.
38. 2. Antioxid Redox Signal 2006;8:1295-305.
39. Jackson JH. Potential molecular mechanisms of oxidant-induced carcinogenesis. Environ Health Perspect 1994;102 Suppl 10:155-7.
40. Tyler DD. Polarographic assay and intracellular distribution of superoxide dismutase in rat liver. Biochem J 1975;147:493-504.
41. Boveris A, Cadenas E, Stoppani AOM. Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem J 1976;156:435-44.
42. Radi R, Turrens JF, Chang LY, Bush KM, Crapo JD, Freeman BA. Detection of catalase in rat heart mitochondria. J Biol Chem 1991;266:22028-34.
43. Bai J, Cederbaum AI. Mitochondrial catalase and oxidative injury. Biol Signals Recept 2001;10:189-99.
44. Petrova VY, Rasheva TV, Kujumdzieva AV. Catalase enzyme in mitochondria of Saccharomyces cerevisiae. Electron J Biotechnol 2002;5:29-41.
45. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α. J Biol Chem 1998;273:6297-302.
46. Wenk J, Brenneisen P, Wlaschek M, et al. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J Biol Chem 1999;274:25869-76.
47. 2 -dependent ERK1/2 activation. J Biol Chem 2001;276:14264-70.
48. Woessner JF, Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-54.
49. 2) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts. Free Radic Biol Med 1997;22:515-24.
50. Kheradmand F, Werner E, Trenble P, Symons M, Werb Z. Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science 1998;280:898-902.
51. Nelson KK, Ranganathan AC, Mansouri J, et al. Elevated SOD2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin Cancer Res 2003;9:424-32.
52. Kamata H, Hirata H. Redox regulation of redox signaling. Cell Signal 1999;11:1-14.
53. Dhar SK, Xu Y, Chen Y, St Clair DK. Specificity protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression. J Biol Chem 2006;281:21698-709.
54. Xu Y, Krishnan A, Wan XS, et al. Mutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase-gene in cancer cells. Oncogene 1999;18:93-102.
55. 58Thr reduces activity by destabilizing the tetrameric interface. Biochemistry 1996;35:4287-97.
56. Wiener HW, Perry RT, Chen Z, Harell LE, Go RCP. A polymorphism in SOD2 is associated with Alzheimer's disease. Genes Brain Behav 2007;6:770-5.
57. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-7.